Covid-19: The E484K mutation and the risks it poses

2021/02/05 by Jacqui Wise · 1 citation
Medicine · Mathematics · #SARS-CoV-2 and COVID-19 Research #COVID-19 Clinical Research Studies #COVID-19 epidemiological studies

paper · doi:10.1136/bmj.n359

openalex publication_date 2021/02/05 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30

Abstract

The mutation E484K, first identified in the South African SARS-CoV-2 variant, has now been identified in the UK fast-spreading variant, prompting fears the virus is evolving further and could become resistant to vaccines. <b>Jacqui Wise</b> looks at what we know so far

Cited by

• Variants of SARS-CoV-2 [wikipedia]

Related

• New mutations raise specter of ‘immune escape’
• Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, South Africa, and other COVID-19-devastated countries
• Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees
• The biological and clinical significance of emerging SARS-CoV-2 variants
• Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern